Adipose tissue lipoma |
Kidney |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Adipose tissue lipoma |
Intestine - Small Intestine |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Adrenal gland - Cortex adenoma |
Adrenal gland - Cortex |
None (spontaneous) |
C3H/HeNCr
inbred
|
8.3 |
37.5 |
|
|
|
|
Summary
|
Adrenal gland - Cortex adenoma |
Adrenal gland - Cortex |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
30 |
|
|
|
|
Summary
|
Adrenal gland - Cortex adenoma |
Adrenal gland - Cortex |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
0 - 4.8 |
65 - 71 |
|
|
|
|
Summary
|
Adrenal gland - Cortex adenoma |
Adrenal gland - Cortex |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.5 - 9.5 |
57 - 65 |
|
|
|
|
Summary
|
Adrenal gland - Cortex carcinoma |
Adrenal gland - Cortex |
None (spontaneous) |
C3H/HeNCr
inbred
|
0 |
0 |
|
|
|
|
Summary
|
Adrenal gland - Cortex carcinoma |
Adrenal gland - Cortex |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.2 |
0 |
|
|
|
|
Summary
|
Adrenal gland - Cortex carcinoma |
Adrenal gland - Cortex |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
0 |
0 |
|
|
|
|
Summary
|
Adrenal gland - Cortex carcinoma |
Adrenal gland - Cortex |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
0 |
|
|
|
|
Summary
|
Adrenal gland - Medulla pheochromocytoma |
Adrenal gland - Medulla |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
|
4.8 |
|
|
|
|
Summary
|
Blood vessel hemangioma |
Liver |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|
Blood vessel hemangioma |
Uterus |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Blood vessel hemangioma |
Ovary |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Blood vessel hemangioma |
Leg |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Blood vessel hemangioma |
Oviduct |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Blood vessel hemangioma |
Heart |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Blood vessel hemangioma |
Kidney |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Blood vessel hemangioma |
Intestine - Small Intestine |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Blood vessel hemangioma |
Spleen |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Blood vessel hemangiosarcoma |
Liver |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Connective tissue - Fibroblast fibrosarcoma |
Preputial gland (male) |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Connective tissue myxoma |
Uterus - Cervix |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Eye - Harderian gland adenoma |
Eye - Harderian gland |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|
Eye - Harderian gland carcinoma |
Eye - Harderian gland |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Leukocyte lymphoma |
Leukocyte |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|
Liver hepatoblastoma |
Liver |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
|
4.8 |
|
|
|
|
Summary
|
Liver hepatocellular adenoma |
Liver |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
18 - 29 |
52 - 76 |
|
|
|
|
Summary
|
Liver hepatocellular adenoma |
Liver |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
13 - 14 |
52 - 90 |
|
|
|
|
Summary
|
Liver hepatocellular adenoma |
Liver |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
8.3 |
35 |
|
|
|
|
Summary
|
Liver hepatocellular adenoma |
Liver |
None (spontaneous) |
C3H/HeNCr
inbred
|
8.3 |
42 |
|
|
|
|
Summary
|
Liver hepatocellular carcinoma |
Liver |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
9.1 - 19 |
26 - 33 |
|
|
|
|
Summary
|
Liver hepatocellular carcinoma |
Liver |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
4.8 - 13 |
35 - 48 |
|
|
|
|
Summary
|
Liver hepatocellular carcinoma |
Liver |
None (spontaneous) |
C3H/HeNCr
inbred
|
4.2 |
12.5 |
|
|
|
|
Summary
|
Liver hepatocellular carcinoma |
Liver |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
8.3 |
8.7 |
|
|
|
|
Summary
|
Liver hepatocellular tumor |
Liver |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
27 - 38 |
65 - 86 |
|
|
|
|
Summary
|
Liver hepatocellular tumor |
Liver |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
19 - 26 |
61 - 90 |
|
|
|
|
Summary
|
Liver hepatocellular tumor |
Liver |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
12.5 |
39 |
|
|
|
|
Summary
|
Liver hepatocellular tumor |
Liver |
None (spontaneous) |
C3H/HeNCr
inbred
|
12.5 |
50 |
|
|
|
|
Summary
|
Lung adenoma |
Lung |
None (spontaneous) |
C3H/HeNCr
inbred
|
4.2 |
17 |
|
|
|
|
Summary
|
Lung adenoma |
Lung |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.2 |
8.7 |
|
|
|
|
Summary
|
Lung adenoma |
Lung |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
8.7 - 9.5 |
24 - 26 |
|
|
|
|
Summary
|
Lung adenoma |
Lung |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
9.1 - 29 |
24 - 43 |
|
|
|
|
Summary
|
Lung carcinoma |
Lung |
None (spontaneous) |
C3H/HeNCr
inbred
|
0 |
0 |
|
|
|
|
Summary
|
Lung carcinoma |
Lung |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.2 |
4.3 |
|
|
|
|
Summary
|
Lung carcinoma |
Lung |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
0 |
4.3 - 4.8 |
|
|
|
|
Summary
|
Lung carcinoma |
Lung |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 - 9.1 |
0 - 9.5 |
|
|
|
|
Summary
|
Lung tumor |
Lung |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
8.3 |
13 |
|
|
|
|
Summary
|
Lung tumor |
Lung |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
8.7 - 9.5 |
29 - 30 |
|
|
|
|
Summary
|
Lung tumor |
Lung |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
18 - 29 |
33 - 43 |
|
|
|
|
Summary
|
Lung tumor |
Lung |
None (spontaneous) |
C3H/HeNCr
inbred
|
4.2 |
17 |
|
|
|
|
Summary
|
Mammary gland adenocarcinoma |
Mammary gland |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Melanocyte melanoma |
Uterus - Cervix |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Mesodermal cell/mesoblast sarcoma |
Skin |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.5 |
|
|
|
|
|
Summary
|
Mesodermal cell/mesoblast sarcoma |
Skin |
None (spontaneous) |
C3H/HeNCr
inbred
|
8.3 |
|
|
|
|
|
Summary
|
Mesodermal cell/mesoblast sarcoma |
Leg |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Mesodermal cell/mesoblast sarcoma |
Liver |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Mesodermal cell/mesoblast sarcoma |
Peritoneum |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Mesodermal cell/mesoblast squamous cell sarcoma |
Forestomach |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Muscle - Smooth leiomyoma |
Uterus |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
|
|
|
|
|
Summary
|
Ovary adenoma |
Ovary |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
17 - 19 |
|
|
|
|
|
Summary
|
Ovary adenoma |
Ovary |
None (spontaneous) |
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary adenoma |
Ovary |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary adenoma |
Ovary |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
19 - 23 |
|
|
|
|
|
Summary
|
Ovary carcinoma |
Ovary |
None (spontaneous) |
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary carcinoma |
Ovary |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary carcinoma |
Ovary |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
0 - 4.3 |
|
|
|
|
|
Summary
|
Ovary carcinoma |
Ovary |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary tumor |
Ovary |
None (spontaneous) |
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary tumor |
Ovary |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Ovary tumor |
Ovary |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
19 - 22 |
|
|
|
|
|
Summary
|
Ovary tumor |
Ovary |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
19 - 23 |
|
|
|
|
|
Summary
|
Oviduct adenoma |
Oviduct |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.5 |
|
|
|
|
|
Summary
|
Oviduct hyperplasia |
Oviduct |
None (spontaneous) |
C3H/HeNCr
inbred
|
12.5 |
|
|
|
|
|
Summary
|
Oviduct hyperplasia |
Oviduct |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
12.5 |
|
|
|
|
|
Summary
|
Oviduct hyperplasia |
Oviduct |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
35 - 48 |
|
|
|
|
|
Summary
|
Oviduct hyperplasia |
Oviduct |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
32 - 43 |
|
|
|
|
|
Summary
|
Renal pelvis papilloma |
Renal pelvis |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Skin squamous cell carcinoma |
Skin |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
|
4.3 |
|
|
|
|
Summary
|
Thyroid gland adenoma |
Thyroid gland |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Ureter transitional cell carcinoma |
Ureter |
None (spontaneous) |
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
Uterus adenoma |
Uterus |
None (spontaneous) |
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Uterus adenoma |
Uterus |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
0 |
|
|
|
|
|
Summary
|
Uterus adenoma |
Uterus |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
4.3 - 4.8 |
|
|
|
|
|
Summary
|
Uterus adenoma |
Uterus |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
4.5 - 4.8 |
|
|
|
|
|
Summary
|
Uterus hyperplasia - cystic |
Uterus |
None (spontaneous) |
C3H/HeNCr
inbred
|
25 |
|
|
|
|
|
Summary
|
Uterus hyperplasia - cystic |
Uterus |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
29 |
|
|
|
|
|
Summary
|
Uterus hyperplasia - cystic |
Uterus |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
61 - 67 |
|
|
|
|
|
Summary
|
Uterus hyperplasia - cystic |
Uterus |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
68 - 71 |
|
|
|
|
|
Summary
|
Uterus lesion |
Uterus |
None (spontaneous) |
C3H/HeNCr
inbred
|
25 |
|
|
|
|
|
Summary
|
Uterus lesion |
Uterus |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
29 |
|
|
|
|
|
Summary
|
Uterus lesion |
Uterus |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
65 - 71 |
|
|
|
|
|
Summary
|
Uterus lesion |
Uterus |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
73 - 76 |
|
|
|
|
|
Summary
|
(Unspecified organ) adenoma |
(Unspecified organ) |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
|
observed |
|
|
|
|
Summary
|
(Unspecified organ) tumor |
(Unspecified organ) |
Chemical/Drug
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|
(Unspecified organ) tumor |
(Unspecified organ) |
None (spontaneous) |
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|
(Unspecified organ) tumor |
(Unspecified organ) |
Chemical/Drug
sodium arsenite
|
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|
(Unspecified organ) tumor |
(Unspecified organ) |
Chemical/Drug
sodium arsenite
12-O-tetradecanoylphorbol-13-acetate (TPA)
|
C3H/HeNCr
inbred
|
observed |
observed |
|
|
|
|
Summary
|